ARTICLE | Company News
Pfizer licenses Valentis' GeneSwitch
October 24, 2001 7:00 AM UTC
VLTS granted PFE a non-exclusive license to its GeneSwitch gene regulation technology for use in PFE's research programs. VLTS retains rights to gene therapy applications. ...